• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Biotechnol . A novel SUMOylation site in the influenza a virus NS1 protein identified with a highly sensitive FRET assay

tetano

Editor, Senior Moderator
J Biotechnol


. 2020 Aug 18;S0168-1656(20)30222-4.
doi: 10.1016/j.jbiotec.2020.08.009. Online ahead of print.
A novel SUMOylation site in the influenza a virus NS1 protein identified with a highly sensitive FRET assay


George Way[SUP] 1 [/SUP], Zhehao Xiong[SUP] 1 [/SUP], Guojun Wang[SUP] 2 [/SUP], Hanchu Dai[SUP] 3 [/SUP], Shasha Zheng[SUP] 3 [/SUP], Adolfo Garc?a-Sastre[SUP] 4 [/SUP], Jiayu Liao[SUP] 5 [/SUP]



Affiliations

Abstract

Nonstructural protein 1 (NS1) of the influenza A virus is a major contributor to the virulence of the seasonal influenza A viruses, in part because it interferes with host viral defense mechanisms. SUMOylation regulates NS1 activity, and several residues of NS1 have been identified with traditional biochemical approaches as acceptor sites for SUMOylation. In this study, we developed a novel FRET assay to assess SUMOylation. Using this assay, we demonstrated that the lysine residue K131 in the effector domain of NS1 is a previously unidentified SUMO acceptor site. A recombinant H1N1 influenza A virus (A/PR/8/34) expressing a K131 SUMOylation-deficient NS1 had a significantly lower growth rate than the wild-type virus. These results suggest that NS1 SUMOylation at K131 is required for the rapid replication of H1N1 influenza viruses. The interaction between the NS1 protein and the host SUMOylation components may serve as a novel target for the development of anti-influenza A drugs.

Keywords: FRET; H1N1; NS1 influenza A virus; SUMOylation.
 
Back
Top